Serum heart-type fatty acid-binding protein concentration positively correlates with the length of aortic dissection

Hiroshi Hazui1, Nobuyuki Negoro, Masayoshi Nishimoto

  • 1Department of Emergency Medicine, Osaka Mishima Emergency and Critical Care Center, Osaka, Japan. hazui112@osaka-mishima.jp

Insights

Elevated heart-type fatty acid-binding protein (H-FABP) in aortic dissection (AD) patients is linked to longer dissections and ascending aorta involvement. This elevation may stem from cardiac, skeletal muscle, or aortic wall release.

Area of Science:

  • Cardiology
  • Biomarkers
  • Aortic Diseases

Background:

  • Heart-type fatty acid-binding protein (H-FABP) is often elevated in patients with aortic dissection (AD).
  • The clinical significance of this H-FABP elevation in AD remains unclear.

Purpose of the Study:

  • To investigate the significance of serum H-FABP levels in patients with aortic dissection.
  • To determine factors associated with positive H-FABP tests in AD patients.

Main Methods:

  • Serum H-FABP concentrations were measured in 63 AD patients.
  • H-FABP positivity was assessed (cutoff: 6.2 ng/ml) and correlated with clinical factors.
  • Multivariate logistic regression analyzed factors associated with H-FABP positivity.

Main Results:

  • 36 out of 63 AD patients (57.1%) had a positive H-FABP test.
  • Positive H-FABP rates were significantly higher in patients with ascending AD (76.7% vs 39.4%, p=0.003).
  • A longer dissection length score was significantly associated with H-FABP positivity (p<0.001) and showed a positive correlation with absolute H-FABP values (r=0.420, p=0.001).

Conclusions:

  • Increased serum H-FABP in AD patients may originate from cardiac muscle, skeletal muscle, or the aortic wall.
  • Physicians should be aware that ascending or long aortic dissections can cause H-FABP elevation, potentially confounding myocardial injury detection.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...